Recommendations for the diagnosis and treatment of Beh?et′s syndrome in China

VernacularTitle:白塞综合征诊疗规范
Author: Wenjie ZHENG ¹ ; Na ZHANG ; Xiaochun ZHU ; Shuhong CHI ; Wen ZHANG ; Wei WEI ; Yan ZHAO ; Yi DONG
Author Information

1. 中国医学科学院　北京协和医学院　北京协和医院风湿免疫科　国家皮肤与免疫疾病临床医学研究中心　疑难重症及罕见病国家重点实验室　风湿免疫病学教育部重点实验室100730
Keywords: Behcet syndrome; Diagnosis; Therapy; Prognosis
From: Chinese Journal of Internal Medicine 2021;60(10):860-867
CountryChina
Language:Chinese
Abstract: Beh?et′s syndrome (BS) is classified among variable vessel vasculitis with unknown etiology and extensively heterogeneous clinical features. It is easily missed or misdiagnosed due to the lack of a specific laboratory diagnosis index. Based on the evidence and guidelines from China and other countries, the Chinese Rheumatology Association developed the standardization of diagnosis and treatment of BS. The purposes are: (1) To standardize the detection and interpretation of key indicators for BS; (2) To standardize rational management for BS patients with topical and systemic organ involvement to reduce complications and improve outcomes.